Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 203
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT07299409 | First-Line Sacituzumab Govitecan in Advanced Untreated Triple-Negative Breast Cancer Patients. | ||
| NCT06678126 | Adaptive Versus Non-adaptive Radiotherapy and 2 Bladder Filling Instructions for Patients With Intermediate or High Risk Localized Prostate Cancer (ARP) | ||
| NCT02869802 | Prospectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic Analysis | ||
| NCT06819969 | The Canadian Lung Outcomes in Users of Vaping Devices Study | ||
| NCT02006979 | Acute Exercise Cardioprotection From Doxorubicin | ||
| NCT03836196 | Optimizing Prostate Cancer Treatment in Men With Advanced Local Disease | ||
| NCT02484131 | Bone Health Management for Women Diagnosed With Breast Cancer | ||
| NCT04831307 | 68Ga-HTK03149 for Use as a Diagnostic Radiopharmaceutical | ||
| NCT05025878 | 13C-Glucose Tracing of Tumour and T Cells in the Ascites of Ovarian Cancer Patients. | ||
| NCT02233933 | Trial of Argon Plasma Coagulation Versus APC and APC and Hemospray in the Treatment of Radiation Proctitis | ||
| NCT01850316 | Hepatocellular Carcinoma Using Stereotactic Body Radiotherapy | ||
| NCT05132244 | Monitoring and Managing Glucose Levels in People With Pancreatic Cancer | ||
| NCT05784428 | Single vs. Multiple Fraction Trial of Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastases/Progression | ||
| NCT01423474 | Prostate Accurately Targeted Radiotherapy Investigation of Overall Treatment Time | ||
| NCT01802905 | Utilization of Genomic Information to Augment Chemotherapy Decision-making for People With Incurable Malignancies | ||
| NCT02627703 | (Oncotype DX®) in Estrogen Receptor Positive (ER+) HER-2 Negative (HER 2-) 1-3 Node Positive (pN1) Breast Cancer | ||
| NCT01772498 | HRV Biofeedback for Brain Tumour Survivors | ||
| NCT00920920 | An International Study on Magnetic Resonance Imaging (MRI)-Guided Brachytherapy in Locally Advanced Cervical Cancer | ||
| NCT03031821 | Metformin in Patients Initiating ADT as Prevention and Intervention of Metabolic Syndrome | ||
| NCT04141397 | Real-world Clinical Effectiveness of Whole Genome and Transcriptome Analysis to Guide Advanced Cancer Care | ||
| NCT00800189 | Evaluation of the Informational Content of Setup Verification Images for Patients Receiving Breast Radiation Therapy (Anterior EPI) | ||
| NCT01830166 | Focal Therapy for Prostate Cancer - A Pilot Study of Focal Low Dose Rate Brachytherapy | ||
| NCT00798083 | Neuropathic Pain Caused by Radiation Therapy | ||
| NCT04626843 | Intermittent Fasting and CLL/SLL | ||
| NCT03790813 | Informative Tools to Optimize Neoadjuvant Therapy in ER Positive, HER2 Negative Breast Cancers | ||
| NCT06835725 | Phase II Randomized Trial of 2 Versus 5 Fraction Prostate Stereotactic Ablative Radiotherapy for Intermediate Risk Prostate Cancer | ||
| NCT05057234 | PRecision Oncology Evidence Development in Cancer Treatment - Liquid | ||
| NCT07755202 | Gilteritinib-Azacitidine-Venetoclax Combination Therapy in Patients With Relapsed/Refractory Leukemia | ||
| NCT01605097 | High Dose Rate Prostate Brachytherapy: Dose Escalation to Dominant Intra-prostatic Nodule | ||
| NCT01803139 | Long Term Results of the Canadian Breast IMRT Study | ||
| NCT04261972 | Cell-free DNA in Hereditary And High-Risk Malignancies 1 | ||
| NCT05570994 | 177Lu-HTK03170 in mCRPC With PSMA Positive Disease | ||
| NCT00519883 | Randomized Anastrozole Exercise Trial | ||
| NCT04911114 | Targeted Physical Activity to Improve Mobility and Falls Risk in Women Living With Ovarian Cancer | ||
| NCT01814865 | Anti-Proliferative Effects and Genomic Alterations of Abiraterone Acetate Compared to an Aromatase Inhibitor in Post-menopausal HR+ Operable Breast Cancer | ||
| NCT02899325 | FDGal PET/CT to Detect Hepatocellular Carcinoma | ||
| NCT06574620 | Using Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment | ||
| NCT04207762 | 18F-AmBF3-TATE PET/CT for Imaging NET Patients | ||
| NCT03583528 | DOTATOC PET/CT for Imaging NET Patients | ||
| NCT00407875 | Intensity Modulated Versus Interstitial - Radiation Therapy | ||
| NCT04610372 | 5500/20 vs. SABR or Brachytherapy for PRimary OligoMetastatic Prostate Cancer Treatment (PROMPT) | ||
| NCT04824339 | Breast Cancer Endocrine Therapy FITness (BE-FIT) Trial. | ||
| NCT00798837 | Intraprostatic MAXimal Simultaneous Boost | ||
| NCT05576831 | STRatIfication of Vulvar Squamous Cell Carcinoma by HPV and p53 Status to Guide Excision | ||
| NCT04814095 | PRecision Oncology Evidence Development in Cancer Treatment - Clinical: PREDiCTc | ||
| NCT04705649 | Tailored Adjuvant Therapy in POLE-mutated and p53-wildtype Early Stage Endometrial Cancer | ||
| NCT01719068 | Early Detection of Lung Cancer and Mesothelioma in Workers Exposed to Asbestos | ||
| NCT04557501 | PSMA PET/CT Guided Intensification of Therapy in Patients at Risk of Advanced Prostate Cancer | ||
| NCT00611650 | Green Tea Extract in Treating Current or Former Smokers With Bronchial Dysplasia | ||
| NCT06200974 | Multi-omic Approach to Study HDR Brachytherapy for Favorable Risk and Low Tier Intermediate Risk Prostate Cancer |
